Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
Esophagus : Official Journal of the Japan Esophageal Society
|
May 16, 2021
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Taroh Satoh, Ken Kato, Takashi Ura, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
November 10, 2020
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Masanobu Takahashi, Ken Kato, Morihito Okada, et al.
Oncology Letters
|
October 11, 2024
Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia
Akihiko Chida, Kenta Kawasaki, Junko Kuramoto, et al.
Clinical Colorectal Cancer
|
November 17, 2019
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial)
Takeshi Suzuki, Yasutaka Sukawa, Chiyo K Imamura, et al.
The Oncologist
|
August 17, 2023
Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis
Kohei Horiuchi, Shinnosuke Ikemura, Takashi Sato, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 13, 2016
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)
Mayuko Saito, Kentaro Yamashita, Yoshiaki Arimura, et al.
Clinical Colorectal Cancer
|
September 18, 2022
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF<sup>V600E</sup> Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)
Keitaro Shimozaki, Kenro Hirata, Taro Sato, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 12, 2012
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
Kensei Yamaguchi, Akira Sawaki, Toshihiko Doi, et al.
Annals of Surgical Oncology
|
August 4, 2019
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer
Tomoya Yokota, Ken Kato, Yasuo Hamamoto, et al.
Eclinicalmedicine
|
February 9, 2026
Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan
Kenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
Esophagus : Official Journal of the Japan Esophageal Society
|
May 16, 2021
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Taroh Satoh, Ken Kato, Takashi Ura, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
November 10, 2020
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Masanobu Takahashi, Ken Kato, Morihito Okada, et al.
Oncology Letters
|
October 11, 2024
Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia
Akihiko Chida, Kenta Kawasaki, Junko Kuramoto, et al.
Clinical Colorectal Cancer
|
November 17, 2019
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial)
Takeshi Suzuki, Yasutaka Sukawa, Chiyo K Imamura, et al.
The Oncologist
|
August 17, 2023
Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis
Kohei Horiuchi, Shinnosuke Ikemura, Takashi Sato, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 13, 2016
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)
Mayuko Saito, Kentaro Yamashita, Yoshiaki Arimura, et al.
Clinical Colorectal Cancer
|
September 18, 2022
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF<sup>V600E</sup> Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)
Keitaro Shimozaki, Kenro Hirata, Taro Sato, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 12, 2012
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
Kensei Yamaguchi, Akira Sawaki, Toshihiko Doi, et al.
Annals of Surgical Oncology
|
August 4, 2019
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer
Tomoya Yokota, Ken Kato, Yasuo Hamamoto, et al.
Eclinicalmedicine
|
February 9, 2026
Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan
Kenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, et al.
Page
of 13